Association between trial registration and treatment effect estimates: A meta-epidemiological study

BMC Medicine

Volumn 14, Issue 1, 2016, Pages

  Dechartres, Agnès ^a,b,c,d   Ravaud, Philippe ^a,b,c,d,e   Atal, Ignacio ^a,d   Riveros, Carolina ^a,b   Boutron, Isabelle ^a,b,c,d  

^a PARIS DESCARTES UNIVERSITY   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d French Cochrane Centre   (France)

^e Mailman School of Public Health ^*  (United States)

Author keywords

Bias; ClinicalTrials.gov; Meta analysis; Meta epidemiology; Randomised controlled trial; Registration

Indexed keywords

CONTROLLED STUDY; DRUG COMBINATION; HUMAN; META ANALYSIS; ODDS RATIO; REGISTER; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); MEDICAL RESEARCH; META ANALYSIS (TOPIC); METHODOLOGY; ORGANIZATION AND MANAGEMENT; PROCEDURES; PUBLICATION; STANDARDS; STATISTICAL BIAS; TREATMENT OUTCOME;

BIAS (EPIDEMIOLOGY); BIOMEDICAL RESEARCH; CLINICAL PROTOCOLS; CLINICAL TRIALS AS TOPIC; HUMANS; META-ANALYSIS AS TOPIC; PUBLICATIONS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 85007413463     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-016-0639-x     Document Type: Article

References (31)

1. DeAngelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA. 2004;292(11):1363-4.
2. De Angelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Is this clinical trial fully registered?-A statement from the International Committee of Medical Journal Editors. N Engl J Med. 2005;352(23):2436-8.
3. Dickersin K, Rennie D. The evolution of trial registries and their use to assess the clinical trial enterprise. JAMA. 2012;307(17):1861-4.
4. Laine C, Horton R, DeAngelis CD, Drazen JM, Frizelle FA, Godlee F, et al. Clinical trial registration-looking back and moving ahead. N Engl J Med. 2007;356(26):2734-6.
5. Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA. 2009;302(9):977-84.
6. van de Wetering FT, Scholten RJ, Haring T, Clarke M, Hooft L. Trial registration numbers are underreported in biomedical publications. PLoS One. 2012;7(11):e49599.
7. Roberts I, Ker K, Edwards P, Beecher D, Manno D, Sydenham E. The knowledge system underpinning healthcare is not fit for purpose and must change. BMJ. 2015;350:h2463.
8. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291(20):2457-65.
9. Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev. 2009;1:MR000006.
10. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ. 2010;340:c365.
11. Dwan K, Gamble C, Williamson PR, Kirkham JJ. Systematic review of the empirical evidence of study publication bias and outcome reporting bias-an updated review. PLoS One 2013;8:e66844.
12. Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM. Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis. PLoS Med. 2009;6(9):e1000144.
13. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252-60.
14. Tovey D, Bero L, Farquhar C, Lasserson T, MacLehose H, Macdonald G, et al. A response to Ian Roberts and his colleagues. Rapid response 2015 Jun 7 to. BMJ. 2015;350:h2463. http://www.bmj.com/content/350/bmj.h2463/rr-3.
15. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
16. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011. Available from: http://handbook.cochrane.org/.
17. Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ. 2001;323(7303):42-6.
18. Sterne JA, Juni P, Schulz KF, Altman DG, Bartlett C, Egger M. Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research. Stat Med. 2002;21(11):1513-24.
19. Emdin C, Odutayo A, Hsiao A, Shakir M, Hopewell S, Rahimi K, et al. Association of cardiovascular trial registration with positive study findings: Epidemiological Study of Randomized Trials (ESORT). JAMA Intern Med. 2015;175(2):304-7.
20. Rasmussen N, Lee K, Bero L. Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials. 2009;10:116.
21. Goodman S, Dickersin K. Metabias: a challenge for comparative effectiveness research. Ann Intern Med. 2011;155(1):61-2.
22. Giraudeau B, Higgins JP, Tavernier E, Trinquart L. Sample size calculation for meta-epidemiological studies. Stat Med. 2016;35(2):239-50.
23. Anderson ML, Chiswell K, Peterson ED, Tasneem A, Topping J, Califf RM. Compliance with results reporting at ClinicalTrials.gov. N Engl J Med. 2015; 372(11):1031-9.
24. Nguyen TA, Dechartres A, Belgherbi S, Ravaud P. Public availability of results of trials assessing cancer drugs in the United States. J Clin Oncol. 2013; 31(24):2998-3003.
25. Prayle AP, Hurley MN, Smyth AR. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. BMJ. 2012;344: d7373.
26. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2012;12:MR000033.
27. Dechartres A, Trinquart L, Faber T, Ravaud P. Empirical evaluation of which trial characteristics are associated with treatment effect estimates. J Clin Epidemiol. 2016. http://dx.doi.org/10.1016/j.jclinepi.2016.04.005.
28. Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med. 2008;5(1):e20.
29. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med. 2010; 7(3):e1000251.
30. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
31. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.